UBS AM’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.36M | Buy |
205,537
+35,948
| +21% | +$719K | ﹤0.01% | 1631 |
|
|
2025
Q4 | $2.77M | Buy |
169,589
+21,202
| +14% | +$320K | ﹤0.01% | 1744 |
|
|
2025
Q3 | $1.73M | Sell |
148,387
-114,261
| -44% | -$1.49M | ﹤0.01% | 1813 |
|
|
2025
Q2 | $3.04M | Sell |
262,648
-6,841,120
| -96% | -$62.4M | ﹤0.01% | 1951 |
|
|
2025
Q1 | $62M | Buy |
7,103,768
+4,987,195
| +236% | +$62.9M | 0.02% | 639 |
|
|
2024
Q4 | $30.4M | Buy |
2,116,573
+193,588
| +10% | +$3.05M | 0.01% | 796 |
|
|
2024
Q3 | $43.4M | Sell |
1,922,985
-3,498
| -0.2% | -$72.3K | 0.01% | 702 |
|
|
2024
Q2 | $37.5M | Buy |
1,926,483
+1,791,802
| +1,330% | +$46.9M | 0.01% | 683 |
|
|
2024
Q1 | $5.05M | Buy |
134,681
+1,717
| +1% | +$75.4K | ﹤0.01% | 1245 |
|
|
2023
Q4 | $7.44M | Sell |
132,964
-777
| -0.6% | -$33.8K | ﹤0.01% | 1097 |
|
|
2023
Q3 | $5.52M | Sell |
133,741
-300
| -0.2% | -$15.6K | ﹤0.01% | 1172 |
|
|
2023
Q2 | $7.48M | Hold |
134,041
| – | – | ﹤0.01% | 1073 |
|
|
2023
Q1 | $7.48M | Buy |
134,041
+5,546
| +4% | +$259K | ﹤0.01% | 1073 |
|
|
2022
Q4 | $4.68M | Sell |
128,495
-1,018
| -0.8% | -$33.3K | ﹤0.01% | 1192 |
|
|
2022
Q3 | $3.69M | Sell |
129,513
-329,829
| -72% | -$12.6M | ﹤0.01% | 1307 |
|
|
2022
Q2 | $20.8M | Sell |
459,342
-95,411
| -17% | -$4.95M | 0.01% | 729 |
|
|
2022
Q1 | $42.2M | Buy |
554,753
+57,624
| +12% | +$5.04M | 0.02% | 654 |
|
|
2021
Q4 | $74.1M | Sell |
497,129
-31,151
| -6% | -$4.77M | 0.03% | 552 |
|
|
2021
Q3 | $76.9M | Buy |
528,280
+10,327
| +2% | +$1.77M | 0.03% | 509 |
|
|
2021
Q2 | $101M | Buy |
517,953
+20,239
| +4% | +$3.66M | 0.04% | 429 |
|
|
2021
Q1 | $90.1M | Sell |
497,714
-123,394
| -20% | -$21.3M | 0.04% | 453 |
|
|
2020
Q4 | $87.9M | Buy |
621,108
+180,577
| +41% | +$26.2M | 0.04% | 444 |
|
|
2020
Q3 | $54.9M | Buy |
440,531
+45,150
| +11% | +$4.74M | 0.03% | 489 |
|
|
2020
Q2 | $35.3M | Buy |
395,381
+32,389
| +9% | +$2.52M | 0.02% | 589 |
|
|
2020
Q1 | $22.6M | Buy |
362,992
+505
| +0.1% | +$39.4K | 0.02% | 643 |
|
|
2019
Q4 | $27.6M | Buy |
362,487
+177,804
| +96% | +$10.7M | 0.02% | 691 |
|
|
2019
Q3 | $9.31M | Buy |
+184,683
| New | +$10.2M | 0.01% | 977 |
|
Other funds holding TXG
AIM
VPM
QCM
VCM
NAMA
